兔抗CD160多克隆抗體

Background:

CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine.

Applications:

ELISA, WB, IHC

Name of antibody:

CD160

Immunogen:

Fusion protein of human CD160

Full name:

CD160 molecule

Synonyms：

NK1; BY55; NK28

SwissProt:

O95971

ELISA Recommended dilution:

2000-5000

IHC positive control:

Human thyroid cancer and human gastric cancer

IHC Recommend dilution:

25-100

WB Predicted band size:

20 kDa

WB Positive control:

Hela cells

WB Recommended dilution:

500-2000